Cargando…
Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
INTRODUCTION: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a debilitating autoimmune neuropathy that is treated with intravenous immunoglobulin (IVIG). The aim of this retrospective study was to investigate the efficacy and safety of the sucrose-free IVIG Octagam® (Octapharma...
Autores principales: | Belmokhtar, Chafké, Lozeron, Pierre, Adams, David, Franques, Jérôme, Lacour, Arnaud, Godet, Etienne, Bataille, Mathieu, Dubourg, Odile, Angibaud, Gilles, Delmont, Emilien, Bouhour, Françoise, Corcia, Philippe, Pouget, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534624/ https://www.ncbi.nlm.nih.gov/pubmed/30903535 http://dx.doi.org/10.1007/s40120-019-0132-5 |
Ejemplares similares
-
Octagam(®) for chronic inflammatory demyelinating polyneuropathy: results from three observational studies
por: Wietek, Stefan
Publicado: (2018) -
Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
por: Rajabally, Yusuf A, et al.
Publicado: (2020) -
Combined Central and Peripheral Demyelination With IgM Anti–Neurofascin 155 Antibodies: Case Report
por: Pegat, Antoine, et al.
Publicado: (2022) -
Autoantibodies to a Nodal Isoform of Neurofascin in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
por: Chauvet, Eline, et al.
Publicado: (2023) -
Depression with Chronic Inflammatory Demyelinating Polyneuropathy
por: Marwale, Arun, et al.
Publicado: (2018)